Kemadrin

Procyclidine, the active ingredient in Kemadrin, is an anticholinergic presented as an oral tablet for oral administration. It works by reducing excessive cholinergic activity in the basal ganglia, thereby helping to control tremor associated with Parkinson's disease and alleviating drug‑induced extrapyramidal symptoms in patients receiving antipsychotic therapy as part of a comprehensive management plan.

GNH USA supplies Kemadrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance and regulatory conformity across European and global markets.

Procyclidine is an anticholinergic used to manage movement disorders related to excessive cholinergic activity. - Parkinson's disease (tremor): Reduces tremor and rigidity associated with the disease. - Drug‑induced extrapyramidal symptoms: Alleviates acute dystonia, parkinsonism, and akathisia caused by antipsychotic medications. - Parkinsonian syndrome secondary to medication: Improves motor control when symptoms arise from drug therapy.

Procyclidine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dry mouth: Reduced salivation leading to thirst. - Blurred vision: Transient visual disturbances. - Constipation: Decreased gastrointestinal motility. - Urinary retention: Difficulty initiating urination.

Serious or Rare Side Effects: - Acute glaucoma: Sudden increase in intra‑ocular pressure. - Severe tachycardia: Rapid heart rate requiring medical attention. - Neuroleptic malignant‑like syndrome: Rare life‑threatening reaction with fever and rigidity.

When prescribing Procyclidine, clinicians should consider several safety precautions. - Assess renal and hepatic function: Adjust use in patients with severe impairment. - Monitor for anticholinergic burden: Caution in elderly or those on multiple anticholinergics. - Avoid in narrow‑angle glaucoma: Risk of precipitating acute attacks. - Caution in patients with tachyarrhythmias: May exacerbate heart rate. - Pregnancy and lactation: Use only if benefit outweighs risk. - Store at ambient temperature: Keep below 25 °C, in original packaging, protected from moisture.

Procyclidine can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents (e.g., atropine, scopolamine): Additive anticholinergic effects may cause severe dryness, constipation, or urinary retention. - Quinidine or other CYP2D6 inhibitors: May increase Procyclidine plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Antipsychotics (e.g., haloperidol): May require dose adjustment to balance dopaminergic and cholinergic activity. - Antihistamines with anticholinergic properties: May enhance side‑effect profile. - Beta‑blockers: Potential for additive cardiovascular effects such as bradycardia.